Obesity
Commentary
10 ways docs sabotage their patients’ weight loss journeys
Stopping medications for obesity when weight is lost. Do you also stop blood pressure medications when they normalize a patient’s blood pressure...
Feature
Few patients with BMI of 30-35 get bariatric surgery
The main reason that more patients with lower BMIs are not being offered surgery is related to insurance coverage and reimbursement, one expert...
Commentary
Does rapid weight loss from GLP-1s decrease muscle mass?
Providers prescribing medications like GLP-1 agonists to treat obesity must also counsel patients about incorporating aerobic exercise and...
Commentary
Has the time come to bury BMI in favor of other screening measures?
While BMI is a quick and inexpensive means to assess obesity, by itself it lacks the necessary components for an accurate diagnosis.
From the Journals
One type of bariatric surgery betters IBD outcomes
Previous studies have shown that bariatric surgery is safe for people with IBD, but there have been few long-term data on whether the weight loss...
Feature
Can berberine live up to the claim that it’s ‘nature’s Ozempic’?
The National Center for Complementary and Integrative Health issued a warning...
Latest News
Evidence weighed for suicide/self-harm with obesity drugs
“It is not yet clear whether the reported cases are linked to the medicines themselves or to the patients’ underlying conditions or other factors...
Commentary
‘Body size is not a choice’ and deserves legal protections
Weight-based discrimination in the United States has increased by an estimated 66% over the past decade, putting it on par with the prevalence of...
Latest News
Treating obesity: Will new drugs end the crisis?
The drugs offer new hope to millions with obesity complications. But to truly turn the tide on our 42% obesity rate, much more work remains to be...
Commentary
Oral GLP-1 agonists could be game changers for obesity
I hope that future developments bring the class to an even wider demographic and perhaps reduce some of the global inequities in managing type 2...
Conference Coverage
Survodutide impresses in phase 2 weight loss trial
Survodutide has received U.S. Food and Drug Administration Fast Track Designation for adults with NASH.